Abstract Body:
Objective:
This study aimed to systematically assess cohort studies examining the prognostic significance of office blood pressure (OBP), 24-hour ambulatory blood pressure monitoring (ABPM), and home blood pressure monitoring (HBPM) in predicting cardiovascular disease risk.
Hypothesis:
Ambulatory blood pressure monitoring and home blood pressure monitoring may demonstrate equivalent efficacy in predicting vascular outcomes
Methods:
A systematic literature search was conducted to identify pertinent outcome studies that investigated OBP, HBPM, and ABPM within the same cohort. A network meta-analysis was performed to compare the aggregated risk estimates for various outcomes across different blood pressure monitoring modalities.
Results:
Of the 4200 articles obtained, 24 satisfied the inclusion criteria. HBP significantly surpassed OBP in predicting cardiovascular events (CVE) (hazard ratios 1.21 [1.02-1.44]). No statistically significant difference was observed in the mean systolic and diastolic blood pressure between HBPM and ABPM, as well as between OBP and ABPM, in relation to predicting CVE, cardiovascular mortality, all-cause mortality, or left ventricular mass index. The ranking probabilities for the highest prognostic for CVE values across the three modalities were 0.6970, 0.2990, and 0.0040, respectively.
Conclusion:
ABPM or HBPM may predict CVE risk with similar prognostic importance.

Keywords: ambulatory blood pressure monitoring, cardiovascular event, home blood pressure monitor, hypertension, incidence, nonfatal

Abbreviations: ABPM, ambulatory blood pressure measurement; BP, blood pressure; CVE, cardiovascular event; HBPM, home blood pressure measurement; OBP, office blood pressure; WCHT, whitecoat hypertension